Skip to main content
SpringerLink
Log in

PROMs for Fibromyalgia

  • Chapter
  • First Online:
Patient Reported Outcome Measures in Rheumatic Diseases

Abstract

Fibromyalgia syndrome (FMS) is a complex syndrome that encompasses a myriad of symptoms without objective signs or lesions. With such a background, FMS is perhaps the rheumatic condition that cries out louder for patient reported outcome measures (PROMs). Unfortunately, neither are there many PROMs that can be used in FMS nor have they been well or fully validated. The symptoms in FMS—pain, sleep quality, fatigue, etc.—are very challenging to measure without error and in a valid manner, as they are all very subjective and interrelated, as well as subjected to multiple confounding factors, including gender and cultural factors. We herein present the PROMs developed specifically for FMS or for aspects within the syndrome and highlight their psychometric properties.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Anonymous. Twenty-second rheumatism review. Review of the American and English literature for the years 1973 and 1974. Arthritis Rheum. [Review]. 1976;19(6 Suppl):973–1223.

    Google Scholar 

  2. Gowers WR. A lecture on lumbago: its lessons and analogues: delivered at the national hospital for the paralysed and epileptic. Br Med J. 1904;1(2246):117–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Anonymous. Implementation of the international statistical classification of diseases and related health problems, tenth revision (icd-10). Epidemiol Bull. 1997;18(1):1–4.

    Google Scholar 

  4. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. [Comparative Study Research Support, Non-U.S. Gov’t]. 1990;33(2):160–72.

    Google Scholar 

  5. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. [Multicenter Study Research Support, Non-U.S. Gov’t]. 2010;62(5):600–10.

    Google Scholar 

  6. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RS, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol. 2011;38(6):1113–22.

    Article  PubMed  Google Scholar 

  7. Katz JD, Mamyrova G, Guzhva O, Furmark L. Gender bias in diagnosing fibromyalgia. Gender Med. [Research Support, Non-U.S. Gov’t]. 2010;7(1):19–27.

    Google Scholar 

  8. Yokota S, Kikuchi M, Miyamae T. Juvenile fibromyalgia: guidance for management. Pediatr Int. [Review]. 2013;55(4):403–9.

    Google Scholar 

  9. Mas AJ, Carmona L, Valverde M, Ribas B. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol. [Research Support, Non-U.S. Gov’t]. 2008;26(4):519–26.

    Google Scholar 

  10. Kashikar-Zuck S, Ting TV. Juvenile fibromyalgia: current status of research and future developments. Nat Rev Rheumatol. [Review]. 2014;10(2):89–96.

    Google Scholar 

  11. Lourenco S, Costa L, Rodrigues AM, Carnide F, Lucas R. Gender and psychosocial context as determinants of fibromyalgia symptoms (fibromyalgia research criteria) in young adults from the general population. Rheumatology (Oxford). 2015;54(10):1806–15.

    Article  Google Scholar 

  12. Rivera J, Rejas-Gutierrez J, Vallejo MA, Esteve-Vives J, De Salas-Cansado M. Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice. Clin Exp Rheumatol. [Multicenter Study Research Support, Non-U.S. Gov’t]. 2012;30(6 Suppl 74):31–8.

    Google Scholar 

  13. Silverman S, Dukes EM, Johnston SS, Brandenburg NA, Sadosky A, Huse DM. The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin. [Research Support, Non-U.S. Gov’t]. 2009;25(4):829–40.

    Google Scholar 

  14. Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med. [Comparative Study Research Support, Non-U.S. Gov’t]. 2004;66(6):837–44.

    Google Scholar 

  15. Hauser W, Hoffmann EM, Wolfe F, Worthing AB, Stahl N, Rothenberg R, et al. Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in fibromyalgia syndrome: a comparison of US and German outpatients. Clin Exp Rheumatol. 2015;33(1 Suppl 88):S86–92.

    PubMed  PubMed Central  Google Scholar 

  16. Talotta R, Atzeni F, Bazzichi L, Giacomelli C, Di Franco M, Salaffi F, et al. Algo-dysfunctional syndromes: a critical digest of the recent literature. Clin Exp Rheumatol. [Review]. 2015;33(1 Suppl 88):S102–8.

    Google Scholar 

  17. Docampo E, Escaramis G, Gratacos M, Villatoro S, Puig A, Kogevinas M, et al. Genome-wide analysis of single nucleotide polymorphisms and copy number variants in fibromyalgia suggest a role for the central nervous system. Pain. [Multicenter Study Research Support, Non-U.S. Gov’t]. 2014;155(6):1102–9.

    Google Scholar 

  18. Landis CA, Lentz MJ, Rothermel J, Riffle SC, Chapman D, Buchwald D, et al. Decreased nocturnal levels of prolactin and growth hormone in women with fibromyalgia. J Clin Endocrinol Metab. [Research Support, U.S. Gov’t, P.H.S.]. 2001;86(4):1672–8.

    Google Scholar 

  19. Togo F, Natelson BH, Adler GK, Ottenweller JE, Goldenberg DL, Struzik ZR, et al. Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia. Exp Biol Med (Maywood). [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. 2009;234(2):232–40.

    Google Scholar 

  20. Mease PJ, Clauw DJ, Arnold LM, Goldenberg DL, Witter J, Williams DA, et al. Fibromyalgia syndrome. J Rheumatol. [Consensus Development Conference]. 2005;32(11):2270–7.

    Google Scholar 

  21. Vincent A, Benzo RP, Whipple MO, McAllister SJ, Erwin PJ, Saligan LN. Beyond pain in fibromyalgia: insights into the symptom of fatigue. Arthritis Res Ther. [Research Support, N.I.H., Extramural Review]. 2013;15(6):221.

    Google Scholar 

  22. Yunus MB, Inanici F, Aldag JC, Mangold RF. Fibromyalgia in men: comparison of clinical features with women. J Rheumatol. [Comparative Study]. 2000;27(2):485–90.

    Google Scholar 

  23. Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, et al. Fibromyalgia syndrome module at omeract 9: domain construct. J Rheumat. [Consensus Development Conference Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. 2009;36(10):2318–29.

    Google Scholar 

  24. Coate L, S. Perrot, Choy E. Generalized pain syndromes Eular textbook on rheumatic diseases. UK: BMJ Group; 2012. p. 917–36.

    Google Scholar 

  25. Bertolucci PH, de Oliveira FF. Cognitive impairment in fibromyalgia. Curr Pain Headache Rep. [Review]. 2013;17(7):344.

    Google Scholar 

  26. Katz RS, Heard AR, Mills M, Leavitt F. The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia. J Clin Rheumatol. 2004;10(2):53–8.

    Article  PubMed  Google Scholar 

  27. Kravitz HM, Katz RS. Fibrofog and fibromyalgia: a narrative review and implications for clinical practice. Rheumatol Int. 2015;35(7):1115–25.

    Article  PubMed  Google Scholar 

  28. Park DC, Glass JM, Minear M, Crofford LJ. Cognitive function in fibromyalgia patients. Arthritis Rheum. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. 2001;44(9):2125–33.

    Google Scholar 

  29. Tesio V, Torta DM, Colonna F, Leombruni P, Ghiggia A, Fusaro E, et al. Are fibromyalgia patients cognitively impaired? Objective and subjective neuropsychological evidence. Arthritis Care Res. 2015;67(1):143–50.

    Article  Google Scholar 

  30. Jones GT, Atzeni F, Beasley M, Fluss E, Sarzi-Puttini P, Macfarlane GJ. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. [Comparative Study Research Support, Non-U.S. Gov’t]. 2015;67(2):568–75.

    Google Scholar 

  31. Hooten WM, Townsend CO, Decker PA. Gender differences among patients with fibromyalgia undergoing multidisciplinary pain rehabilitation. Pain Med. 2007;8(8):624–32.

    Article  PubMed  Google Scholar 

  32. Wolfe F, Ross K, Anderson J, Russell IJ. Aspects of fibromyalgia in the general population: Sex, pain threshold, and fibromyalgia symptoms. J Rheumatol. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. 1995;22(1):151–6.

    Google Scholar 

  33. Yunus MB, Celiker R, Aldag JC. Fibromyalgia in men: comparison of psychological features with women. J Rheumatol. [Comparative Study]. 2004;31(12):2464–7.

    Google Scholar 

  34. Prados G, Miro E. [Fibromyalgia and sleep: a review]. Rev Neurol. [Research Support, Non-U.S. Gov’t Review]. 2012;54(4):227–40.

    Google Scholar 

  35. Prados G, Miro E, Martinez MP, Sanchez AI, Lopez S, Saez G. Fibromyalgia: gender differences and sleep-disordered breathing. Clin Exp Rheumatol. [Comparative Study]. 2013;31(6 Suppl 79):S102–10.

    Google Scholar 

  36. Racine M, Castarlenas E, de la Vega R, Tome-Pires C, Sole E, Miro J, et al. Sex differences in psychological response to pain in patients with fibromyalgia syndrome. Clin J Pain. [Research Support, Non-U.S. Gov’t]. 2015;31(5):425–32.

    Google Scholar 

  37. Miro E, Martinez MP, Sanchez AI, Prados G, Lupianez J. Men and women with fibromyalgia: relation between attentional function and clinical symptoms. Br J Health Psychol. 2015;20(3):632–47.

    Article  PubMed  Google Scholar 

  38. Ruiz-Montero PJ, Van Wilgen CP, Segura-Jimenez V, Carbonell-Baeza A, Delgado-Fernandez M. Illness perception and fibromyalgia impact on female patients from Spain and the Netherlands: do cultural differences exist? Rheumatol Int. 2015;13:1985–93.

    Article  Google Scholar 

  39. Marques M, De Gucht V, Leal I, Maes S. A cross-cultural perspective on psychological determinants of chronic fatigue syndrome: a comparison between a Portuguese and a Dutch patient sample. Int J Behav Med. [Comparative Study Research Support, Non-U.S. Gov’t]. 2013;20(2):229–38.

    Google Scholar 

  40. Karasz A, McKinley PS. Cultural differences in conceptual models of everyday fatigue: a vignette study. J Health Psychol. [Research Support, N.I.H., Extramural]. 2007;12(4):613–626.

    Google Scholar 

  41. Skapinakis P, Lewis G, Mavreas V. Cross-cultural differences in the epidemiology of unexplained fatigue syndromes in primary care. Br J Psychiatry. [Multicenter Study Research Support, Non-U.S. Gov’t]. 2003;182:205–9.

    Google Scholar 

  42. Hobara M. Beliefs about appropriate pain behavior: cross-cultural and sex differences between Japanese and Euro-Americans. Eur J Pain. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. 2005;9(4):389–93.

    Google Scholar 

  43. Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Associations between psychosocial factors and pain intensity, physical functioning, and psychological functioning in patients with chronic pain: a cross-cultural comparison. Clin J Pain. [Comparative Study Research Support, Non-U.S. Gov’t]. 2014;30(8):713–23.

    Google Scholar 

  44. Sanders SH, Brena SF, Spier CJ, Beltrutti D, McConnell H, Quintero O. Chronic low back pain patients around the world: cross-cultural similarities and differences. Clin J Pain. [Clinical Trial Comparative Study]. 1992;8(4):317–23.

    Google Scholar 

  45. Ferreira-Valente MA, Ribeiro JL, Jensen MP, Almeida R. Coping with chronic musculoskeletal pain in Portugal and in the United States: a cross-cultural study. Pain Med. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S.]. 2011;12(10):1470–80.

    Google Scholar 

  46. Koffman J, Morgan M, Edmonds P, Speck P, Higginson I. Cultural meanings of pain: a qualitative study of black Caribbean and white British patients with advanced cancer. Palliative Med. [Comparative Study Multicenter Study Research Support, Non-U.S. Gov’t]. 2008;22(4):350–9.

    Google Scholar 

  47. Diller A. Cross-cultural pain semantics. Pain. [Comparative Study]. 1980;9(1):9–26.

    Google Scholar 

  48. Moldofsky H. The significance, assessment, and management of nonrestorative sleep in fibromyalgia syndrome. CNS Spectrums. [Review]. 2008;13(3 Suppl 5):22–26.

    Google Scholar 

  49. Kurtze N, Gundersen KT, Svebak S. The role of anxiety and depression in fatigue and patterns of pain among subgroups of fibromyalgia patients. Br J Med Psychol. [Research Support, Non-U.S. Gov’t]. 1998;71 (Pt 2):185–194.

    Google Scholar 

  50. Wolfe F, Michaud K. Severe rheumatoid arthritis (ra), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia. J Rheumatol. [Research Support, Non-U.S. Gov't]. 2004;31(4):695–700.

    Google Scholar 

  51. Ranzolin A, Brenol JC, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, et al. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum. [Research Support, Non-U.S. Gov’t]. 2009;61(6):794–800.

    Google Scholar 

  52. Naranjo A, Ojeda S, Francisco F, Erausquin C, Rua-Figueroa I, Rodriguez-Lozano C. Fibromyalgia in patients with rheumatoid arthritis is associated with higher scores of disability. Ann Rheum Dis. [Letter]. 2002;61(7):660–1.

    Google Scholar 

  53. Dhir V, Lawrence A, Aggarwal A, Misra R. Fibromyalgia is common and adversely affects pain and fatigue perception in north Indian patients with rheumatoid arthritis. J Rheumatol. 2009;36(11):2443–8.

    Article  PubMed  Google Scholar 

  54. Almodovar R, Carmona L, Zarco P, Collantes E, Gonzalez C, Mulero J, et al. Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Clin Exp Rheumatol. 2010;28(6 Suppl 63):S33–9.

    CAS  PubMed  Google Scholar 

  55. Aloush V, Ablin JN, Reitblat T, Caspi D, Elkayam O. Fibromyalgia in women with ankylosing spondylitis. Rheumatol Int. 2007;27(9):865–8.

    Article  PubMed  Google Scholar 

  56. Staud R. Are patients with systemic lupus erythematosus at increased risk for fibromyalgia? Curr Rheumat Rep. [Review]. 2006;8(6):430–35.

    Google Scholar 

  57. Bennett R. The concurrence of lupus and fibromyalgia: implications for diagnosis and management. Lupus. [Review]. 1997;6(6):494–9.

    Google Scholar 

  58. Pompa A, Clemenzi A, Troisi E, Pace L, Casillo P, Catani S, et al. Chronic pain in multiple sclerosis patients: utility of sensory quantitative testing in patients with fibromyalgia comorbidity. Eur Neurol. 2015;73(5–6):257–63.

    Article  PubMed  Google Scholar 

  59. Clemenzi A, Pompa A, Casillo P, Pace L, Troisi E, Catani S, et al. Chronic pain in multiple sclerosis: is there also fibromyalgia? An observational study. Med Sci Monitor. [Observational Study Research Support, Non-U.S. Gov’t]. 2014;20:758–66.

    Google Scholar 

  60. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8:27.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Wright M. Widespread body pain and mortality. Diagnosing fibromyalgia stops doctors from thinking. Br Med J. [Comment Letter]. 2002;324(7332):300.

    Google Scholar 

  62. Chamizo-Carmona E. [Is there an association between fibromyalgia and an increase in comorbidity: neoplastic and cardiovascular diseases, infections and mortality?]. Article in Spanish. Reumatol Clin. 2005;1(4):200–10.

    Article  CAS  PubMed  Google Scholar 

  63. Wolfe F, Hassett AL, Walitt B, Michaud K. Mortality in fibromyalgia: a study of 8,186 patients over thirty-five years. Arthritis Care Res. [Comparative Study]. 2011;63(1):94–101.

    Google Scholar 

  64. Dreyer L, Kendall S, Danneskiold-Samsoe B, Bartels EM, Bliddal H. Mortality in a cohort of Danish patients with fibromyalgia: increased frequency of suicide. Arthritis Rheum. [Research Support, Non-U.S. Gov’t]. 2010;62(10):3101–8.

    Google Scholar 

  65. Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R, et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res. 2014;66(9):1364–73.

    Article  Google Scholar 

  66. Choy EH, Arnold LM, Clauw DJ, Crofford LJ, Glass JM, Simon LS, et al. Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. 2009;36(10):2330–4.

    Google Scholar 

  67. Castrejon I, Gossec L, Carmona L. The EULAR outcome measures library: an evolutional database of validated patient-reported instruments. Ann Rheum Dis. [Letter]. 2015;74(2):475–6.

    Google Scholar 

  68. Bennett R. The fibromyalgia impact questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005;23(5 Suppl 39):S154–62.

    CAS  PubMed  Google Scholar 

  69. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18(5):728–33.

    CAS  PubMed  Google Scholar 

  70. Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. [Research Support, Non-U.S. Gov’t Validation Studies]. 2009;11(4):R120.

    Google Scholar 

  71. Ediz L, Hiz O, Toprak M, Tekeoglu I, Ercan S. The validity and reliability of the Turkish version of the revised fibromyalgia impact questionnaire. Clin Rheumatol. [Validation Studies]. 2011;30(3):339–46.

    Google Scholar 

  72. Zachrisson O, Regland B, Jahreskog M, Kron M, Gottfries CG. A rating scale for fibromyalgia and chronic fatigue syndrome (the fibrofatigue scale). J Psychosom Res. [Clinical Trial Controlled Clinical Trial]. 2002;52(6):501–9.

    Google Scholar 

  73. Brand K, Littlejohn G, Kristjanson L, Wisniewski S, Hassard T. The fibromyalgia bladder index. Clin Rheumatol. 2007;26(12):2097–103.

    Article  PubMed  Google Scholar 

  74. Vallejo MA, Rivera J, Esteve-Vives J, Rejas J. A confirmatory study of the combined index of severity of fibromyalgia (ICAF*): factorial structure, reliability and sensitivity to change. Health Qual Life outcomes. [Research Support, Non-U.S. Gov’t Validation Studies]. 2011;9:39.

    Google Scholar 

  75. Boomershine CS, Emir B, Wang Y, Zlateva G. Simplifying fibromyalgia assessment: The VASFIQ brief symptom scale. Ther Adv Musculoskelet Dis. 2011;3(5):215–26.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Fries JF. The hierarchy of quality-of-life assessment, the health assessment questionnaire (HAQ), and issues mandating development of a toxicity index. Control Clin Trials. [Research Support, U.S. Gov’t, P.H.S.]. 1991;12(4 Suppl):106S–117S.

    Google Scholar 

  77. Wolfe F, Hawley DJ, Goldenberg DL, Russell IJ, Buskila D, Neumann L. The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM health assessment questionnaire. J Rheumatol. [Evaluation Studies]. 2000;27(8):1989–99.

    Google Scholar 

  78. El Miedany Y, El Gaafary M, Youssef S, El Aroussy N, Ahmed I, Palmer D. Towards a multidimensional patient reported outcome measures assessment: Development and validation of a questionnaire for patients with fibromyalgia. EULAR: Ann Rheum Dis. 2013;72 Suppl 3:719.

    Google Scholar 

  79. Cuesta-Vargas A, Luciano JV, Penarrubia-Maria MT, Garcia-Campayo J, Fernandez-Vergel R, Arroyo-Morales M, et al. Clinical dimensions of fibromyalgia symptoms and development of a combined index of severity: the CODI index. Qual Life Res. [Research Support, Non-U.S. Gov’t]. 2013;22(1):153–60.

    Google Scholar 

  80. Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ, et al. The development and psychometric validation of the central sensitization inventory. Pain Pract. 2012;12(4):276–85.

    Article  PubMed  Google Scholar 

  81. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737–45.

    Article  PubMed  Google Scholar 

  82. Rivera J, Gonzalez T. The fibromyalgia impact questionnaire: a validated spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol. [Clinical Trial Randomized Controlled Trial Validation Studies]. 2004;22(5):554–60.

    Google Scholar 

  83. Ablin JN, Odes L, Neumann L, Buskila D. The Hebrew version of the fibrofatigue scale: validation of a questionnaire for assessment of fibromyalgia and chronic fatigue syndrome. Rheumatol Int. [Validation Studies]. 2010;30(9):1173–6.

    Google Scholar 

  84. Finckh A, Morabia A, Deluze C, Vischer T. Validation of questionnaire-based response criteria of treatment efficacy in the fibromyalgia syndrome. Arthritis Care Res. 1998;11(2):116–23.

    Article  CAS  PubMed  Google Scholar 

  85. Sarzi-Puttini P, Atzeni F, Turiel M, Furlan R, Vulpio L, Carrabba M, et al. The Italian version of the fibrofatigue scale, a reliable tool for the evaluation of fibromyalgia symptoms. J Psychosom Res. [Validation Studies]. 2004;56(2):213–6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto de Salud Musculoesquelética, Calle Conde de la Cimera, 6, Madrid, 28040, Spain

    Loreto Carmona M.D., Ph.D. & Rafael J. Curbelo M.Sc., Ph.D.

  2. Instituto de Salud Osteoarticular, Conde de la Cimera 6, Madrid, 28040, Spain

    Concepción González Isabel Ph.D.

Authors
  1. Loreto Carmona M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rafael J. Curbelo M.Sc., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Concepción González Isabel Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Loreto Carmona M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Honorary Senior Clinical Lecturer, King’s College London, London, United Kingdom

    Yasser El Miedany

Appendices

Appendix 1

The FIQ Directions and Questions

Directions: For questions 1–3, please circle the number that best describes how you did overall for the past week. If you don’t normally do something that is asked, cross the question out.

Question 1.

Were you able to:

Always

Most

Occasionally

Never

1. Do shopping?

0

1

2

3

2. Do laundry with washer and dryer?

0

1

2

3

3. Prepare meals?

0

1

2

3

4. Wash dishes/cooking utensils by hand?

0

1

2

3

5. Vacuum a rug?

0

1

2

3

6. Make beds?

0

1

2

3

7. Walk several blocks?

0

1

2

3

8. Visit friends or relatives?

0

1

2

3

9. Do yard work?

0

1

2

3

10. Drive a car?

0

1

2

3

11. Climb stairs?

0

1

2

3

Question 2. Of the 7 days in the past week, how many days did you feel good?

0

1

2

3

4

5

6

7

Question 3. How many days last week did you miss work, including housework, because of fibromyalgia?

0

1

2

3

4

5

6

7

Directions: For the remaining items, mark the point on the line that best indicates how you felt overall of the past week.

Question 4. When you worked, how much did pain or other symptoms of your fibromyalgia interfere with your ability to do your work, including housework?

No problem with work

Great difficulty with work

Question 5. How bad has your pain been?

No pain

Very severe pain

Question 6. How tired have you been?

No tiredness

Very tired

Question 7. How have you felt when you get up in the morning?

Awoke well rested

Awoke very tired

Question 8. How bad has your stiffness been?

No stiffness

Very stiff

Question 9. How nervous or anxious have you felt?

Not anxious

Very anxious

Question 10. How depressed or blue have you felt?

Not depressed

Very depressed

Reprinted with permission of the developers Carol Burckhardt, Sharon Clark, and Robert Bennett at Oregon Health and Science University in Portland, Oregon

Appendix 2

figure a
figure b
figure c
figure d
figure e
figure f
figure g
figure h
figure i
figure j
figure k
figure l
figure m
figure n
figure o

Reprinted with permission from Fibromyalgia, published by the Spanish Ministry of Health: http://www.msssi.gob.es/profesionales/prestacionesSanitarias/publicaciones/docs/fibromialgia.pdf

Appendix 3: Multi-dimensional Questionnaire for Patient Reported Outcome Measures: Fibromyalgia

figure pfigure p

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Carmona, L., Curbelo, R.J., Isabel, C.G. (2016). PROMs for Fibromyalgia. In: El Miedany, Y. (eds) Patient Reported Outcome Measures in Rheumatic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-32851-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32851-5_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32849-2

  • Online ISBN: 978-3-319-32851-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation